Featured Resource
SCIg in Multifocal Motor Neuropathy
Hans D. Katzberg, MD, MSc, FRCP(C)
University Health Network /Toronto General Hospital Canada
10:32 MIN
  • MMN

Hear the results of a trial to determine the feasibility of switching patients with multifocal motor neuropathy on intravenous to subcutaneous immunoglobulin.

Improving CIDP Diagnosis: The Challenges of Under and Over Diagnosis
Jeffrey A. Allen, MD
University of Minnesota
12:30 MIN
  • CIDP
Understand the challenges associated with accurately diagnosing CIDP
Incidence of GBS and CIDP Following Influenza Vaccination
Peter Donofrio, MD
Vanderbilt University Medical Center, Nashville, TN, USA
25:18 MIN
  • CIDP
  • GBS

Gain an understanding of the existing surveillance data, studies and facts associated with the influenza vaccine as it relates to GBS and CIDP.

CIDP Assessment Tools: Rasch Overall Disability Score
Jeffrey A. Allen, MD
University of Minnesota
02:15 MIN
  • CIDP
Hear a brief description of the Rasch version of the Overall Disability Score used in CIDP diagnosis and treatment
GBS and Zika Virus
Kenneth C. Gorson, M.D.
Tufts University School of Medicine
19:15 MIN
  • GBS
Understand the latest information on the Zika Virus and its relationship to Guillain-Barre´ syndrome
Overview and Treatment of Guillain-Barré Syndrome (GBS)
David R. Cornblath, MD
Johns Hopkins University, Baltimore, MD, USA
7:23 MIN
  • GBS

Learn more about the features, symptoms, diagnosis, and treatment of GBS.

CIDP Assessment Tools: Medical Research Council Sum Score
Jeffrey A. Allen, MD
University of Minnesota
02:11 MIN
  • CIDP
Understand how the Medical Research Council (MRC) Sum Score can be used for evaluating muscle strength in CIDP
Overview and Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Vera Bril, BSc, FRCPC, MD
University of Toronto,Toronto, Canada
5:24 MIN
  • CIDP

Learn more about the mechanism of action, symptoms, diagnosis, and treatment of CIDP.

Subcutaneous Immunoglobulins (SCIg) in Responders to Intravenous Immunoglobulins (IVIg) with Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and Multifocal Motor Neuropathy (MMN)
Nabil Moumane, MD
Medical Affairs and Pharmacology, CSL Behring
3:00 MIN
  • CIDP
  • MMN

Hear why SCIg may be a better option for long-term treatment of patients on Immunoglobulin therapy with difficult venous access.

20% Subcutaneous Immunoglobulin for Maintenance Treatment in Chronic Inflammatory Demyelinating Polyneuropathy (PATH): a Randomized, Double-blind, Placebo-controlled, Phase 3 Trial
Vera Bril, BSc, FRCPC, MD
University of Toronto,Toronto, Canada
15:31 MIN
  • CIDP
Learn about the PATH study results and SCIG (subcutaneous immunoglobulin) treatment in CIDP
Consistency Over Time of Strength and Disability Measurements in Patients with CIDP on Stable IgG Therapy
Mel Berger, MD, PhD
Medical Research Strategy, CSL Behring
8:25 MIN
  • CIDP

Hear the results of a study to understand wear-off effects in CIDP patients during IVIg therapy.

The GRIPPER study: Quantifying IVIG Treatment-Related Fluctuations in CIDP Using Daily Grip Strength Measurements
Jeffrey A. Allen, MD
University of Minnesota
12:15 MIN
  • CIDP
Learn more about grip strength as an outcome measure in CIDP and how it is utilized in the Gripper Study as a daily measure of treatment-related fluctuations in IVIg-treated patients.
Global Multifocal Motor Neuropathy Quality of Life Patient Survey
Jonathan S. Katz, MD
Forbes Norris MDA/ALS Research Center at the California Pacific Medical Center in San Francisco, California
09:51 MIN
  • MMN
Examine a quality of life patient study that identifies needs in education and treatment for patients with MMN.
CIDP Assessment Tools: Grip Strength
Jeffrey A. Allen, MD
University of Minnesota
01:52 MIN
  • CIDP
Listen to a discussion about Discussing tools that are commonly used to measure grip strength in CIDP
Overview and Treatment of Multifocal Motor Neuropathy
Claudia Sommer, MD
University of Würzburg, Würzburg, Germany
12:34 MIN
  • MMN
Learn about the diagnosis and treatment of multifocal motor neuropathy
Dosing Schedules for IVIg: The Use of an Algorithm as a Suggestion for Personalized Dosing
Michael Lunn, PhD

National Hospital for Neurology and Neurosurgery, Queen Square, London

14:01 MIN
  • CIDP

Learn how an algorithm could be used to personalize dosing schedules for IVIg.

Optimizing IgG Therapy in Chronic Autoimmune Neuropathies
Jeffrey A. Allen, MD
University of Minnesota
12:50 MIN
  • CIDP
  • MMN
Review options for individualizing treatment and tools used to assess IgG performance
Fatigue in CIDP
Karissa Gable, MD
Duke University Medical Center in Durham, North Carolina
09:29 MIN
  • CIDP
Engage in a presentation on the comparison between active and remission disease states in CIDP.
Guillain-Barre Syndrome (GBS): Typical and Atypical Clinical Presentations
Thomas Harbo, MD, PhD
Aarhus University Hospital in Aarhus, Denmark
15:18 MIN
  • CIDP
  • GBS
Learn more about the importance of understanding typical and atypical presentations of GBS, including features of clinically distinct variants and subtypes, proper diagnosis, and initiation of appropriate treatment.
CIDP Assessment Tools: INCAT
Jeffrey A. Allen, MD
University of Minnesota
03:32 MIN
  • CIDP
Learn about the The INCAT scores and variations of them used to evaluate outcome measures for immune-mediated neuropathies
Electrophysiologic Findings In Multifocal Motor Neuropathy
Jonathan S. Katz, MD
Forbes Norris MDA/ALS Research Center at the California Pacific Medical Center in San Francisco, California
09:15 MIN
  • MMN
Explore electrophysiologic findings of MMN in addition to the classical electrophysiological conduction block
Pathogenesis and Mechanism of Action of Inflammatory Neuropathies
Richard A. Lewis, MD
Cedars-Sinai Medical Center, Los Angeles, CA, USA
13:53 MIN
  • CIDP
  • GBS
  • MMN

Find out what pathogenic processes are involved in acute and chronic inflammatory neuropathies, including GBS, CIDP, and MMN.

IgG Levels and Wear Off Reflect Administration and Outcome
5:51 MIN
  • CIDP
  • GBS
Learn more about how IgG levels and their wear off reflect treatment administration and outcomes in individual IV- or SCIg-treated patients with immunodeficiency and peripheral inflammatory neuropathy disorders.
SCIg in Multifocal Motor Neuropathy
Hans D. Katzberg, MD, MSc, FRCP(C)
University Health Network /Toronto General Hospital Canada
  • MMN

Hear the results of a trial to determine the feasibility of switching patients with multifocal motor neuropathy on intravenous to subcutaneous immunoglobulin.

Improving CIDP Diagnosis: The Challenges of Under and Over Diagnosis
Jeffrey A. Allen, MD
University of Minnesota
  • CIDP
Understand the challenges associated with accurately diagnosing CIDP
Incidence of GBS and CIDP Following Influenza Vaccination
Peter Donofrio, MD
Vanderbilt University Medical Center, Nashville, TN, USA
  • CIDP
  • GBS

Gain an understanding of the existing surveillance data, studies and facts associated with the influenza vaccine as it relates to GBS and CIDP.

CIDP Assessment Tools: Rasch Overall Disability Score
Jeffrey A. Allen, MD
University of Minnesota
  • CIDP
Hear a brief description of the Rasch version of the Overall Disability Score used in CIDP diagnosis and treatment
GBS and Zika Virus
Kenneth C. Gorson, M.D.
Tufts University School of Medicine
  • GBS
Understand the latest information on the Zika Virus and its relationship to Guillain-Barre´ syndrome
Overview and Treatment of Guillain-Barré Syndrome (GBS)
David R. Cornblath, MD
Johns Hopkins University, Baltimore, MD, USA
  • GBS

Learn more about the features, symptoms, diagnosis, and treatment of GBS.

CIDP Assessment Tools: Medical Research Council Sum Score
Jeffrey A. Allen, MD
University of Minnesota
  • CIDP
Understand how the Medical Research Council (MRC) Sum Score can be used for evaluating muscle strength in CIDP
Overview and Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Vera Bril, BSc, FRCPC, MD
University of Toronto,Toronto, Canada
  • CIDP

Learn more about the mechanism of action, symptoms, diagnosis, and treatment of CIDP.

Subcutaneous Immunoglobulins (SCIg) in Responders to Intravenous Immunoglobulins (IVIg) with Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and Multifocal Motor Neuropathy (MMN)
Nabil Moumane, MD
Medical Affairs and Pharmacology, CSL Behring
  • CIDP
  • MMN

Hear why SCIg may be a better option for long-term treatment of patients on Immunoglobulin therapy with difficult venous access.

20% Subcutaneous Immunoglobulin for Maintenance Treatment in Chronic Inflammatory Demyelinating Polyneuropathy (PATH): a Randomized, Double-blind, Placebo-controlled, Phase 3 Trial
Vera Bril, BSc, FRCPC, MD
University of Toronto,Toronto, Canada
  • CIDP
Learn about the PATH study results and SCIG (subcutaneous immunoglobulin) treatment in CIDP
Consistency Over Time of Strength and Disability Measurements in Patients with CIDP on Stable IgG Therapy
Mel Berger, MD, PhD
Medical Research Strategy, CSL Behring
  • CIDP

Hear the results of a study to understand wear-off effects in CIDP patients during IVIg therapy.

The GRIPPER study: Quantifying IVIG Treatment-Related Fluctuations in CIDP Using Daily Grip Strength Measurements
Jeffrey A. Allen, MD
University of Minnesota
  • CIDP
Learn more about grip strength as an outcome measure in CIDP and how it is utilized in the Gripper Study as a daily measure of treatment-related fluctuations in IVIg-treated patients.
Global Multifocal Motor Neuropathy Quality of Life Patient Survey
Jonathan S. Katz, MD
Forbes Norris MDA/ALS Research Center at the California Pacific Medical Center in San Francisco, California
  • MMN
Examine a quality of life patient study that identifies needs in education and treatment for patients with MMN.
CIDP Assessment Tools: Grip Strength
Jeffrey A. Allen, MD
University of Minnesota
  • CIDP
Listen to a discussion about Discussing tools that are commonly used to measure grip strength in CIDP
Overview and Treatment of Multifocal Motor Neuropathy
Claudia Sommer, MD
University of Würzburg, Würzburg, Germany
  • MMN
Learn about the diagnosis and treatment of multifocal motor neuropathy
Dosing Schedules for IVIg: The Use of an Algorithm as a Suggestion for Personalized Dosing
Michael Lunn, PhD

National Hospital for Neurology and Neurosurgery, Queen Square, London

  • CIDP

Learn how an algorithm could be used to personalize dosing schedules for IVIg.

Optimizing IgG Therapy in Chronic Autoimmune Neuropathies
Jeffrey A. Allen, MD
University of Minnesota
  • CIDP
  • MMN
Review options for individualizing treatment and tools used to assess IgG performance
Fatigue in CIDP
Karissa Gable, MD
Duke University Medical Center in Durham, North Carolina
  • CIDP
Engage in a presentation on the comparison between active and remission disease states in CIDP.
Guillain-Barre Syndrome (GBS): Typical and Atypical Clinical Presentations
Thomas Harbo, MD, PhD
Aarhus University Hospital in Aarhus, Denmark
  • CIDP
  • GBS
Learn more about the importance of understanding typical and atypical presentations of GBS, including features of clinically distinct variants and subtypes, proper diagnosis, and initiation of appropriate treatment.
CIDP Assessment Tools: INCAT
Jeffrey A. Allen, MD
University of Minnesota
  • CIDP
Learn about the The INCAT scores and variations of them used to evaluate outcome measures for immune-mediated neuropathies
Electrophysiologic Findings In Multifocal Motor Neuropathy
Jonathan S. Katz, MD
Forbes Norris MDA/ALS Research Center at the California Pacific Medical Center in San Francisco, California
  • MMN
Explore electrophysiologic findings of MMN in addition to the classical electrophysiological conduction block
Pathogenesis and Mechanism of Action of Inflammatory Neuropathies
Richard A. Lewis, MD
Cedars-Sinai Medical Center, Los Angeles, CA, USA
  • CIDP
  • GBS
  • MMN

Find out what pathogenic processes are involved in acute and chronic inflammatory neuropathies, including GBS, CIDP, and MMN.

IgG Levels and Wear Off Reflect Administration and Outcome
  • CIDP
  • GBS
Learn more about how IgG levels and their wear off reflect treatment administration and outcomes in individual IV- or SCIg-treated patients with immunodeficiency and peripheral inflammatory neuropathy disorders.
Video Library
NOW PLAYING
10:32
SCIg in Multifocal Motor Neuropathy

Hear the results of a trial to determine the feasibility of switching patients with multifocal motor neuropathy on intravenous to subcutaneous immunoglobulin.

NOW PLAYING
12:30
Improving CIDP Diagnosis: The Challenges of Under and Over Diagnosis
Understand the challenges associated with accurately diagnosing CIDP
NOW PLAYING
25:18
Incidence of GBS and CIDP Following Influenza Vaccination

Gain an understanding of the existing surveillance data, studies and facts associated with the influenza vaccine as it relates to GBS and CIDP.

NOW PLAYING
02:15
CIDP Assessment Tools: Rasch Overall Disability Score
Hear a brief description of the Rasch version of the Overall Disability Score used in CIDP diagnosis and treatment
NOW PLAYING
19:15
GBS and Zika Virus
Understand the latest information on the Zika Virus and its relationship to Guillain-Barre´ syndrome
NOW PLAYING
7:23
Overview and Treatment of Guillain-Barré Syndrome (GBS)

Learn more about the features, symptoms, diagnosis, and treatment of GBS.

NOW PLAYING
02:11
CIDP Assessment Tools: Medical Research Council Sum Score
Understand how the Medical Research Council (MRC) Sum Score can be used for evaluating muscle strength in CIDP
NOW PLAYING
5:24
Overview and Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Learn more about the mechanism of action, symptoms, diagnosis, and treatment of CIDP.

NOW PLAYING
3:00
Subcutaneous Immunoglobulins (SCIg) in Responders to Intravenous Immunoglobulins (IVIg) with Chronic...

Hear why SCIg may be a better option for long-term treatment of patients on Immunoglobulin therapy with difficult venous access.

NOW PLAYING
15:31
20% Subcutaneous Immunoglobulin for Maintenance Treatment in Chronic Inflammatory Demyelinating Poly...
Learn about the PATH study results and SCIG (subcutaneous immunoglobulin) treatment in CIDP
NOW PLAYING
8:25
Consistency Over Time of Strength and Disability Measurements in Patients with CIDP on Stable IgG Th...

Hear the results of a study to understand wear-off effects in CIDP patients during IVIg therapy.

NOW PLAYING
12:15
The GRIPPER study: Quantifying IVIG Treatment-Related Fluctuations in CIDP Using Daily Grip Strength...
Learn more about grip strength as an outcome measure in CIDP and how it is utilized in the Gripper Study as a daily measure of treatment-related fluctuations in IVIg-treated patients.
NOW PLAYING
09:51
Global Multifocal Motor Neuropathy Quality of Life Patient Survey
Examine a quality of life patient study that identifies needs in education and treatment for patients with MMN.
NOW PLAYING
01:52
CIDP Assessment Tools: Grip Strength
Listen to a discussion about Discussing tools that are commonly used to measure grip strength in CIDP
NOW PLAYING
12:34
Overview and Treatment of Multifocal Motor Neuropathy
Learn about the diagnosis and treatment of multifocal motor neuropathy
NOW PLAYING
14:01
Dosing Schedules for IVIg: The Use of an Algorithm as a Suggestion for Personalized Dosing

Learn how an algorithm could be used to personalize dosing schedules for IVIg.

NOW PLAYING
12:50
Optimizing IgG Therapy in Chronic Autoimmune Neuropathies
Review options for individualizing treatment and tools used to assess IgG performance
NOW PLAYING
09:29
Fatigue in CIDP
Engage in a presentation on the comparison between active and remission disease states in CIDP.
NOW PLAYING
15:18
Guillain-Barre Syndrome (GBS): Typical and Atypical Clinical Presentations
Learn more about the importance of understanding typical and atypical presentations of GBS, including features of clinically distinct variants and subtypes, proper diagnosis, and initiation of appropriate treatment.
NOW PLAYING
03:32
CIDP Assessment Tools: INCAT
Learn about the The INCAT scores and variations of them used to evaluate outcome measures for immune-mediated neuropathies
NOW PLAYING
09:15
Electrophysiologic Findings In Multifocal Motor Neuropathy
Explore electrophysiologic findings of MMN in addition to the classical electrophysiological conduction block
NOW PLAYING
13:53
Pathogenesis and Mechanism of Action of Inflammatory Neuropathies

Find out what pathogenic processes are involved in acute and chronic inflammatory neuropathies, including GBS, CIDP, and MMN.

NOW PLAYING
5:51
IgG Levels and Wear Off Reflect Administration and Outcome
Learn more about how IgG levels and their wear off reflect treatment administration and outcomes in individual IV- or SCIg-treated patients with immunodeficiency and peripheral inflammatory neuropathy disorders.
Slides & Posters Library
PDF
SCIg in Multifocal Motor Neuropathy

Hear the results of a trial to determine the feasibility of switching patients with multifocal motor neuropathy on intravenous to subcutaneous immunoglobulin.

PDF
Improving CIDP Diagnosis: The Challenges of Under and Over Diagnosis
Understand the challenges associated with accurately diagnosing CIDP
PDF
Incidence of GBS and CIDP Following Influenza Vaccination

Gain an understanding of the existing surveillance data, studies and facts associated with the influenza vaccine as it relates to GBS and CIDP.

PDF
GBS and Zika Virus
Understand the latest information on the Zika Virus and its relationship to Guillain-Barre´ syndrome
PDF
Overview and Treatment of Guillain-Barré Syndrome (GBS)

Learn more about the features, symptoms, diagnosis, and treatment of GBS.

PDF
Overview and Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Learn more about the mechanism of action, symptoms, diagnosis, and treatment of CIDP.

PDF
Subcutaneous Immunoglobulins (SCIg) in Responders to Intravenous Immunoglobulins (IVIg) with Chronic...

Hear why SCIg may be a better option for long-term treatment of patients on Immunoglobulin therapy with difficult venous access.

PDF
20% Subcutaneous Immunoglobulin for Maintenance Treatment in Chronic Inflammatory Demyelinating Poly...
Learn about the PATH study results and SCIG (subcutaneous immunoglobulin) treatment in CIDP
PDF
Consistency Over Time of Strength and Disability Measurements in Patients with CIDP on Stable IgG Th...

Hear the results of a study to understand wear-off effects in CIDP patients during IVIg therapy.

PDF
The GRIPPER study: Quantifying IVIG Treatment-Related Fluctuations in CIDP Using Daily Grip Strength...
Learn more about grip strength as an outcome measure in CIDP and how it is utilized in the Gripper Study as a daily measure of treatment-related fluctuations in IVIg-treated patients.
PDF
Global Multifocal Motor Neuropathy Quality of Life Patient Survey
Examine a quality of life patient study that identifies needs in education and treatment for patients with MMN.
PDF
Overview and Treatment of Multifocal Motor Neuropathy
Learn about the diagnosis and treatment of multifocal motor neuropathy
PDF
Dosing Schedules for IVIg: The Use of an Algorithm as a Suggestion for Personalized Dosing

Learn how an algorithm could be used to personalize dosing schedules for IVIg.

PDF
Optimizing IgG Therapy in Chronic Autoimmune Neuropathies
Review options for individualizing treatment and tools used to assess IgG performance
PDF
Fatigue in CIDP
Engage in a presentation on the comparison between active and remission disease states in CIDP.
PDF
Guillain-Barre Syndrome (GBS): Typical and Atypical Clinical Presentations
Learn more about the importance of understanding typical and atypical presentations of GBS, including features of clinically distinct variants and subtypes, proper diagnosis, and initiation of appropriate treatment.
PDF
Electrophysiologic Findings In Multifocal Motor Neuropathy
Explore electrophysiologic findings of MMN in addition to the classical electrophysiological conduction block
PDF
Pathogenesis and Mechanism of Action of Inflammatory Neuropathies

Find out what pathogenic processes are involved in acute and chronic inflammatory neuropathies, including GBS, CIDP, and MMN.

PDF
IgG Levels and Wear Off Reflect Administration and Outcome
Learn more about how IgG levels and their wear off reflect treatment administration and outcomes in individual IV- or SCIg-treated patients with immunodeficiency and peripheral inflammatory neuropathy disorders.
Back to Top